Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus.

Reynard O, Schaeffer E, Volchkova VA, Cimarelli A, Mueller CG, Volchkov VE.

J Infect Dis. 2018 Nov 22;218(suppl_5):S666-S671. doi: 10.1093/infdis/jiy464.

PMID:
30239745
2.

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

Pyankov OV, Setoh YX, Bodnev SA, Edmonds JH, Pyankova OG, Pyankov SA, Pali G, Belford S, Lu L, La M, Lovrecz G, Volchkova VA, Chappell KJ, Watterson D, Marsh G, Young PR, Agafonov AA, Farmer JF, Volchkov VE, Suhrbier A, Khromykh AA.

Sci Rep. 2017 Feb 3;7:41537. doi: 10.1038/srep41537.

3.

RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S226-33. doi: 10.1093/infdis/jiv309. Epub 2015 Jul 2.

PMID:
26138826
4.

Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.

Dolnik O, Volchkova VA, Escudero-Perez B, Lawrence P, Klenk HD, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8. doi: 10.1093/infdis/jiv268. Epub 2015 Jun 19.

PMID:
26092855
5.

Ebola Virus GP Gene Polyadenylation Versus RNA Editing.

Volchkova VA, Vorac J, Repiquet-Paire L, Lawrence P, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S191-8. doi: 10.1093/infdis/jiv150. Epub 2015 Apr 2.

PMID:
25838269
6.

A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.

Pyankov OV, Bodnev SA, Pyankova OG, Solodkyi VV, Pyankov SA, Setoh YX, Volchkova VA, Suhrbier A, Volchkov VV, Agafonov AA, Khromykh AA.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S368-71. doi: 10.1093/infdis/jiv019. Epub 2015 Mar 2.

7.

Shed GP of Ebola virus triggers immune activation and increased vascular permeability.

Escudero-Pérez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE.

PLoS Pathog. 2014 Nov 20;10(11):e1004509. doi: 10.1371/journal.ppat.1004509. eCollection 2014 Nov.

8.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

9.

Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.

Page A, Volchkova VA, Reid SP, Mateo M, Bagnaud-Baule A, Nemirov K, Shurtleff AC, Lawrence P, Reynard O, Ottmann M, Lotteau V, Biswal SS, Thimmulappa RK, Bavari S, Volchkov VE.

Cell Rep. 2014 Mar 27;6(6):1026-1036. doi: 10.1016/j.celrep.2014.02.027. Epub 2014 Mar 13.

10.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2014 May;159(5):1229-37. doi: 10.1007/s00705-013-1877-2. Epub 2013 Nov 5.

11.

Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.

Mathieu C, Guillaume V, Volchkova VA, Pohl C, Jacquot F, Looi RY, Wong KT, Legras-Lachuer C, Volchkov VE, Lachuer J, Horvat B.

J Virol. 2012 Oct;86(19):10766-75. doi: 10.1128/JVI.01203-12. Epub 2012 Jul 25.

12.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.

PMID:
21987773
13.

Role of VP30 phosphorylation in the Ebola virus replication cycle.

Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S934-40. doi: 10.1093/infdis/jir320.

PMID:
21987772
14.

Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.

Mateo M, Carbonnelle C, Martinez MJ, Reynard O, Page A, Volchkova VA, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S892-6. doi: 10.1093/infdis/jir311.

PMID:
21987766
15.

VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.

Mateo M, Carbonnelle C, Reynard O, Kolesnikova L, Nemirov K, Page A, Volchkova VA, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S1011-20. doi: 10.1093/infdis/jir338.

PMID:
21987737
16.

Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.

Prins KC, Delpeut S, Leung DW, Reynard O, Volchkova VA, Reid SP, Ramanan P, Cárdenas WB, Amarasinghe GK, Volchkov VE, Basler CF.

J Virol. 2010 Mar;84(6):3004-15. doi: 10.1128/JVI.02459-09. Epub 2010 Jan 13.

17.

Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.

Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE.

J Virol. 2009 Sep;83(18):9596-601. doi: 10.1128/JVI.00784-09. Epub 2009 Jul 8.

18.

Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.

Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF.

J Virol. 2009 Aug;83(16):7828-41. doi: 10.1128/JVI.02610-08. Epub 2009 Jun 10.

19.

Polymorphism of filovirus glycoproteins.

Volchkov VE, Volchkova VA, Dolnik O, Feldmann H, Klenk HD.

Adv Virus Res. 2005;64:359-81. No abstract available.

PMID:
16139600

Supplemental Content

Loading ...
Support Center